Vanguard Personalized Indexing Management, LLC Madrigal Pharmaceuticals, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $6.61 Billion
- Q1 2025
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 963 shares of MDGL stock, worth $263,958. This represents 0.0% of its overall portfolio holdings.
Number of Shares
963
Previous 790
21.9%
Holding current value
$263,958
Previous $243,000
30.86%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding MDGL
# of Institutions
367Shares Held
23.3MCall Options Held
979KPut Options Held
459K-
Janus Henderson Group PLC London, X02.21MShares$605 Million0.42% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.1MShares$575 Million39.89% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.02MShares$554 Million10.84% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$546 Million10.82% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$541 Million7.8% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $4.69B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...